Protalix BioTherapeutics (PLX) Profit After Tax Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 606.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 606.13% |
| Dec 31, 2025 | -184.76% |
| Sep 30, 2025 | -27.22% |
| Jun 30, 2025 | 107.44% |
| Mar 31, 2025 | 21.24% |
| Dec 31, 2024 | 207.45% |
| Sep 30, 2024 | 274.73% |
| Jun 30, 2024 | -111.39% |
| Mar 31, 2024 | -46.76% |
| Dec 31, 2023 | -61.60% |
| Sep 30, 2023 | 48.08% |
| Jun 30, 2023 | 462.56% |
| Mar 31, 2023 | -36.96% |
| Dec 31, 2022 | 43.90% |
| Sep 30, 2022 | 15.05% |
| Jun 30, 2022 | 52.55% |
| Mar 31, 2022 | 61.00% |
| Dec 31, 2021 | -2,196.54% |
| Sep 30, 2021 | 7.82% |
| Jun 30, 2021 | -168.41% |
| Mar 31, 2021 | -500.34% |
| Dec 31, 2020 | 9.28% |
| Sep 30, 2020 | -27.95% |
| Jun 30, 2020 | 45.91% |
| Mar 31, 2020 | 120.15% |
| Dec 31, 2019 | 105.36% |
| Sep 30, 2019 | 33.11% |
| Jun 30, 2019 | 8.50% |
| Mar 31, 2019 | -0.35% |
| Dec 31, 2018 | 59.16% |
| Sep 30, 2018 | 53.47% |
| Jun 30, 2018 | -1,980.44% |
| Mar 31, 2018 | 87.76% |
| Dec 31, 2017 | -446.41% |
| Sep 30, 2017 | -56.89% |
| Jun 30, 2017 | 104.15% |
| Mar 31, 2017 | -587.93% |
| Dec 31, 2016 | 80.39% |
| Sep 30, 2016 | -90.84% |
| Jun 30, 2016 | -75.53% |
| Mar 31, 2016 | -32.01% |
| Mar 31, 2015 | 11.33% |
| Mar 31, 2014 | -69.98% |
| Dec 31, 2013 | -80.54% |
| Sep 30, 2013 | -4.89% |
| Jun 30, 2013 | -170.91% |
| Mar 31, 2013 | 26.81% |
| Dec 31, 2012 | -10.82% |
| Sep 30, 2012 | 38.26% |
| Jun 30, 2012 | 170.44% |
| Mar 31, 2012 | -16.86% |
| Dec 31, 2011 | -4.51% |
| Sep 30, 2011 | -258.73% |
| Jun 30, 2011 | -36.33% |